Cumberland Pharmaceuticals (CPIX) Inventory Average (2011 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Inventory Average came in at $5.8 million in Q1 2026, up 44.21% year-on-year from $4.0 million in Q1 2025, and up 27.5% quarter-over-quarter from $4.6 million in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Inventory Average (2011 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Inventory Average across 16 years of filings, most recently posting $5.8 million for Q1 2026.
- Inventory Average for Q1 2026 came in at $5.8 million, up 44.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.8 million (up 44.21% YoY), and the FY2025 annual result was $5.1 million, up 18.77% from the prior year.
- Inventory Average came in at $5.8 million for Q1 2026 at Cumberland Pharmaceuticals, up from $4.6 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $10.6 million in Q2 2023 to a low of $3.1 million in Q3 2025.
- The 5-year median for Inventory Average is $5.8 million (2026), against an average of $6.8 million.
- Across the five-year window, Inventory Average plunged 59.12% in 2024 and surged 44.21% in 2026, its largest moves.
- Cumberland Pharmaceuticals' Inventory Average stood at $10.3 million in 2022, then tumbled by 35.26% to $6.6 million in 2023, then plunged by 35.92% to $4.3 million in 2024, then increased by 7.65% to $4.6 million in 2025, then gained by 27.5% to $5.8 million in 2026.
- The last three Inventory Average figures came in at $5.8 million (Q1 2026), $4.6 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.51 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 180.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 131.60 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 66.75 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.73 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 266.66 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 63.01 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 79.60 Mn |
| 10 | Cumberland Pharmaceuticals | 87.59 Mn | 76.25 Mn | 7.20 Mn | 5.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.84 Mn |
| Dec 31, 2025 | 4.58 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 3.66 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Sep 30, 2024 | 4.41 Mn |
| Jun 30, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.47 Mn |
| Dec 31, 2023 | 6.64 Mn |
| Sep 30, 2023 | 9.80 Mn |
| Jun 30, 2023 | 10.55 Mn |
| Mar 31, 2023 | 10.02 Mn |
| Dec 31, 2022 | 10.26 Mn |
| Sep 30, 2022 | 10.03 Mn |
| Jun 30, 2022 | 9.65 Mn |
| Mar 31, 2022 | 9.15 Mn |
| Dec 31, 2021 | 9.35 Mn |
| Sep 30, 2021 | 10.18 Mn |
| Jun 30, 2021 | 10.06 Mn |